Shandong Shengli Biological Engineering Co., Ltd. was founded in 2004. It is mainly based on biological fermentation technology to produce animal-specific antibiotic raw materials, veterinary drug preparations and feed additives. It has been approved as a national "high-tech enterprise", "national green factory", Won the honorary title of "Advanced Collective of Central Enterprise", "Advanced Primary Party Organization of Central Enterprise", National High-tech Zone Gazelle Enterprise, China's Top 100 Innovative Capabilities, and ranked among the top ten national veterinary APIs and the top ten veterinary drug manufacturers in Shandong Province .
Shengli Biotechnology is located in the High-tech Industrial Development Zone of Jining City, Shandong Province, covering an area of more than 416 acres. It currently has flavomycin, tiamulin, hainanmycin, monensin, enramycin, nasitide, and adriamycin. Products such as veramycin. Among them, Hainanmycin is the only animal-specific antibiotic with independent intellectual property rights in China.
The company "Zero 483" passed the US FDA on-site audit, and established and improved the quality management system in strict accordance with the current GMP regulations in Europe and the United States, and passed the ISO9001, ISO14001, and OHSAS18001 management system certifications. The main products have been certified and registered in dozens of overseas countries and regions. Tiamulin raw materials are the first to obtain the EU COS certificate in China, and the first batch of enramycin to obtain the approval number in China, 80% tiamulin The premix has obtained the Japanese FMA certificate; the tiamulin, flavomycin, monensin, and salinomycin premix products have obtained the Australian APVMA certificate. The company's products have been sold in more than 40 countries and regions overseas, based on China's global layout, and built a global marketing service network system.